PepsiCo's Snack Sales Stall Despite 15% Price Cuts as GLP-1 Use Surges
PEP is trading near its 52-week low of $133.75 (3.6% above the low).
Summary
PepsiCo's North American food business saw flat volumes in Q2 despite slashing prices up to 15% on Lay's, Doritos, and other core snacks. The article highlights a structural headwind: 21% of U.S. households now use GLP-1 weight-loss drugs, up from 9% in early 2025, directly cutting into salty snack demand. This follows last week's Q2 report where the company beat on revenue but warned of a gradual recovery. The contrast with Coca-Cola's 4% beverage volume growth in the same region underscores PepsiCo's snack-heavy portfolio vulnerability. Activist investor Elliott Management's $4 billion stake adds pressure to revamp the soda business and consider asset sales. The shift from mindless snacking to intentional, health-focused eating threatens the 58% of revenue PepsiCo derives from food brands. Management's acknowledgment of a slower turnaround and the need for faster innovation in functional products signals potential strategic pivots ahead.
At the time of this announcement, PEP was trading at $138.60 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $189B. The 52-week trading range was $133.75 to $171.48. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.